Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Proteome Sciences' Multiplex Phosphoprotein Assay and More


Proteome Sciences this week introduced its SysQuant Assay, a multiplexed mass spec-based assay for quantification of phosphoproteins.

The assay is capable of measuring phosphorylation levels at more than 1,000 sites in a single experiment and can be used in a variety of sample types including cell cultures, xenograft tumor tissue, and patient biopsies, the company said.

Origene this week released its UltraMAB line of antibodies, which are validated using the company's 10K High Density Protein Microarray Technology.

The UltraMAB antibodies are screened against more than 10,000 human proteins to identify the most specific reagents, the company said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more